biosciences

Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026

April 13, 2026 09:00 ET  | Source: Senti Biosciences, Inc. SOUTH SAN FRANCISCO, Calif., April 13, 2026 (GLOBE NEWSWIRE) --…

3 days ago

Artelo Biosciences Announces $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

March 27, 2026 10:40 ET  | Source: Artelo Biosciences SOLANA BEACH, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences,…

3 weeks ago

Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE Cell-Therapy Platform Toward First-in-Human Study

Collaboration supports IND-enabling development and a planned Phase 1/2a first-in-human clinical study in type 1 diabetesCARY, N.C. and NEW YORK,…

3 weeks ago

Pacira BioSciences Reaffirms Commitment to Shareholder Value Creation

-- Issues Statement in Response to DOMA’s Nomination of Director Candidates --  -- No Shareholder Action Required at This Time…

1 month ago

CORRECTING & REPLACING — MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism

Following End-of-Phase 2 meeting, MBX remains on track to initiate Phase 3 in Q3 2026 March 09, 2026 10:21 ET…

1 month ago

Cogent Biosciences Highlights Additional Data with Six Bezuclastinib Posters from SUMMIT Trial at 2026 AAAAI Annual Meeting

February 28, 2026 09:45 ET  | Source: Cogent Biosciences, Inc. Bezuclastinib mean TSS reduction deepens to –32.0 points at 48…

2 months ago

Lifespan Vision Ventures Co-Leads Sift Biosciences’ $3.7M Pre-Seed Financing

NORWALK, Conn., Feb. 18, 2026 /PRNewswire/ -- Lifespan Vision Ventures, an investment firm focused on therapeutics that improve human healthspan,…

2 months ago

Waters Completes Combination with BD’s Biosciences & Diagnostic Solutions Businesses

Announces appointment of Claire M. Fraser, Ph.D., to its Board of DirectorsForms a global life sciences and diagnostics leader focused…

2 months ago

Alamar Biosciences Announces Launch of NULISAqpcr AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the…

3 months ago

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investorsStephen Williams, MD, Ph.D. joins as Chief Scientific OfficerRebecca…

3 months ago